Omega-3 fatty acids do not protect against CVD whereas palmitate is strongly detrimental The Alaska Inuit studies

Sven Ebbesson


Omega-3 FAs do not prevent plaque formation and CVD.  The overwhelming evidence from 3 Alaskan Inuit studies (involving 1635 participants) reveal that marine ω-3 fatty acids are not associated with either plaque or CVD.  Even with an average consumption of 5 g of marine ω-3 FAs a day, the participants had more plaque than is reported for other US populations.  On the other hand, excessive plasma concentration of palmitate, presumably related to palmitate and sugar consumption, is strongly detrimental to the cardiovascular system as a whole, as all CVD risk factors are associated with palmitate concentration in plasma.  These conclusions confirm the results of the Swedish ULSAM 30 year prospective study, which linked high plasma concentrations of palmitate to cardiovascular mortality with no significant association between CVD mortality and plasma levels of ω-3 FAs.


The principal investigator (S.E.) has personally advised each participant about their individual screening results and their responsible health care providers about the results, conclusions of the studies and recommendations for prevention of CVD and diabetes.


omega-3, palmitate, stroke, heart disease, diabetes

Full Text:

 Subscribers Only


Dyerberg J, Bang HO, Stoffersen E. Eicosapentanoic acid and prevention of thrombosis and atherosclerosis? Lancet. 1978;117-19.

Burr ML, Gilbert JF, Holliday RM, et al. Effects of changes in fat fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet. 1989;ii:757-61.

GISSI-Prevenzione Investigators. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-prevenzione trial. Lancet 1999;354:447-55.

Ebbesson SOE, Roman MJ, Devereux RB, Kaufman D, Fabsitz RR, MacCluer JW, Dyke B, Laston S, Wenger CR, Comuzzie AG, Romenesko T, Ebbesson LOE, Nobmann ED, Howard BV (2007) Consumption of omega-3 fatty acids is not associated with a reduction in carotid atherosclerosis: The Genetics of Coronary Artery Disease in Alasks Natives study. Atherosclerosis. 2007; 199:346-353.

Ebbesson SOE, Risica PM, Ebbesson LOE, Kennish JM. Eskimos have CHD despite high consumption of omega-3 fatty acids; The Alaska Siberia Project. Int. J Circumpolar Health. 2005;64:416-424.

Ebbesson SOE, Voruganti VS, Higgins PB, Fabsitz RR, Ebbesson LO, Laston S, Harris WL, Kennish J, Umans BD, Wang W, Devereux RB, Okin PM, Weissman NJ, MacCluer JW, Umans JG, Howard BV.2015 Fatty acids linked to cardiovascular mortality are associated with risk factors. IntJ Circumpolar Health. 74:28055

Ebbesson SOE, Laston S, Wenger CR, et al. Recruitment and community interactions in the GOCADAN study. Int. J Circumpolar Health. 2006;65:23-32.

Ebbesson SOE, Ebbesson LOE, Swenson M, Kennish JM, Robbins DC.2005. A successful Diabetes Prevention study in Eskimos: The Alaska Siberia Project. Int J Circumpol Health 64:409-424.

Warensjo E, Sundsrom J, Vessby B, Cederholm T, Riserus U. Markers of dietary fat quality and fatty acid desaturation as predictors of total and cardiovascular mortality: a population-based prospective study. Am J Clin Nutr. 2008;88:203-9.

Nobmann ED, Ebbesson SOE, White RG, Schraer CD, Lanier AP, Bulkow LR. Dietary intakes among Siberian Yupiks of Alaska and implications for cardiovascular disease. Int J Circumpolar Health. 1998;57:4-17.

Risica PM, Nobmann ED, Caulfield LE, Schraer C, Ebbesson SO. Springtime macronutrient intake of Alaska Natives of the Norton Sound area. Int J Circumpolar Health. 2005;64:222-233.

Ebbesson SOE, Adler AI, Risica PM, et al. Cardiovascular disease and risk factors in three Alaskan Eskimo populations: The Alaska-Siberia Project. Int. J. Circumpolar Health. 2005 64:378-399.

Ebbesson, SOE, Schraer, CD, Adler, A, Risica, PM, Robbins, DC, Yeh, J.. Go, O, and Ebbesson, LOE. 1998. Diabetes mellitus and impaired glucose tolerance in three Alaskan Eskimo populations: The Alaska-Siberia Project. Diabetes Care. 21:563–569.

Ebbesson SOE, Risica PM, Ebbesson LOE, Kennish JM, Tejero ME. 2005.Omega 3 fatty acids improve glucose tolerance and components of the metabolic syndrome in Alaskan Eskimos: The Alaska Siberia Project. Int. J. Circumpol. Health 64:396-407.

Ebbesson, SOE, Kennish, J, Ebbesson, LOE, Go, O, and Yeh, J. 1998. Diabetes is related to fatty acid imbalance in Eskimos. Int. J. Circumpol. Health 58:108-119.

Howard BV, Devereux RB, Cole SA, et al. A Genetic and Epidemiologic Study of Cardiovascular Disease in Alaska Natives (GOCADAN): Design and Methods. Int J Circumpolar Health. 2005;64:206-221.

Howe PRC, Lungerhausen Y, Rogers PF, Gerkens JF, Head RJ, Smith RM. Effects of dietary sodium and fish oil on blood pressure development in strokeprone

spontaneously hypertensive rats. J Hypertens 1991; 9:639-44.

Goodfellow J, Bellamy MF, Ramsey MW, Jones CJ,Lewis MJ Dietary supplementation with marine omega-3 fatty acids improve systemic large artery endothelial function in subjects with hypercholesterolemia. J Am Coll Cardiol. 2000 Feb;35(2): 265-70.

Trimble B, Hamel R, Gorelick P, Horner R, Longstreth W. Alaska Native Stroke Registry. Int J Stroke 2007;2:60-61.

Virchow R. Phlogose und thrombose im gefässystem. In: Gesammelte abhandlungen zur wissenschaftlichen medizin. Frankfurt: Staatsdruckerei Frankfurt; 1856.

Vessby B, Aro A, Skarfors E, Berglund L, Salminen I, Lithell H. The risk to develop NIDDM is related to the fatty acid composition of the serum cholesterol esters. Diabetes 1994;43:1353-1357.

Ebbesson SOE, Lopez-Alvarenga JC, Oikin PM, Devereux RB, Tejero ME, Harris WS, Ebbesson LOE, MacCluer JW, Wenger C, Laston S, Fabsitz RR, Kennish J, Howard WJ, Howard BV, Comuzzie AG. 2012. Heart rate is associated with markers of fatty acid desaturation: The GOCADAN Study. Int J Circumpolar Health. 71:17343. doi:10.3402/ijch.v71i0.17343.

Maynard JE, Hammes LM, Kester FE. Mortality due to heart disease among Alaskan Natives 1955-65. Public Health Reports 1967; 82:714-20.

Daley CA, Abbott A, Doyle PS, Nader GA, Larson S. A review of fatty acid profiles and antioxidant content in grass-fed and grain-fed beef. Nutrition 2010; 1-12.

Riserus R. Fatty acids and insulin sensitivity. Curr Opin Clin Nutr Metab Care. 2008;11:100-5.

Ebbesson,SOE, Tejero ME, Lopez-Alvarenga JC, Harris WS, Ebbesson LOE, Devereux RB, MacCluer JW, RomeskoT, Wenger C, Laston S, Fabsitz RR, Howard WM, Howard BV, Comuzzie AG. 2010 Individual Saturated Fatty Acids are associated with different components of insulin resistance and glucose metabolism: the GOCADAN Study. Int J Circumpolar Health. Sep;69(4):344-51.

Cutchins A, Roman MJ, Devereux RB, Ebbesson SO, Umans JG, Zhu J, Weissman NJ, Howard BV.2008 Prevalence and correlates of Subclinical Atherosclerosis in Alaska Eskimos: The GOCADAN Study.Stroke Nov.39(11):3079-82.

Albert CM, Campos H, Stampfer MJ, et al. Blood levels of long-chain n-3 fatty acids and the risk of sudden death. New Engl J Med. 2002;346:1113-8.



  • There are currently no refbacks.
Copyright 2016. All rights reserved.